Duncan Gregory Scott 4
4 · Virios Therapeutics, Inc. · Filed Jun 30, 2022
Insider Transaction Report
Form 4
Duncan Gregory Scott
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Stock Option (right to buy)
2022-06-23+90,000→ 90,000 totalExercise: $4.23Exp: 2032-06-23→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]The stock option vests one-third on June 23, 2023 and 1/24th monthly thereafter.